ENVESTNET ASSET MANAGEMENT INC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,025,142
-25.2%
33,414
-2.3%
0.00%
-100.0%
Q2 2023$1,370,114
-3.4%
34,193
-1.6%
0.00%0.0%
Q1 2023$1,417,984
+70.5%
34,746
+61.3%
0.00%
Q4 2022$831,814
-39.4%
21,544
-16.5%
0.00%
-100.0%
Q3 2022$1,372,000
-9.2%
25,798
-0.5%
0.00%0.0%
Q2 2022$1,511,000
-26.4%
25,922
-3.7%
0.00%0.0%
Q1 2022$2,054,000
+34.4%
26,914
+6.0%
0.00%0.0%
Q4 2021$1,528,000
+15.9%
25,398
+7.9%
0.00%0.0%
Q3 2021$1,318,000
+24.0%
23,532
+34.3%
0.00%0.0%
Q2 2021$1,063,000
-10.8%
17,525
+3.0%
0.00%0.0%
Q1 2021$1,192,000
+45.4%
17,010
+24.1%
0.00%0.0%
Q4 2020$820,000
+5.8%
13,709
+6.3%
0.00%0.0%
Q3 2020$775,000
+203.9%
12,891
+165.4%
0.00%
Q2 2020$255,000
-22.7%
4,858
-33.4%
0.00%
Q4 2019$330,000
+35.8%
7,295
+30.5%
0.00%
Q2 2019$243,000
+492.7%
5,588
+341.0%
0.00%
Q2 2018$41,000
-2.4%
1,267
-6.6%
0.00%
Q1 2018$42,000
-49.4%
1,356
-26.2%
0.00%
Q4 2017$83,000
+15.3%
1,837
-3.8%
0.00%
Q3 2017$72,000
+7.5%
1,909
+36.7%
0.00%
Q2 2017$67,000
+1575.0%
1,396
+1339.2%
0.00%
Q1 2017$4,0000.0%97
-19.8%
0.00%
Q4 2016$4,000
-94.7%
121
-91.6%
0.00%
Q1 2016$76,000
+2433.3%
1,437
+5426.9%
0.00%
Q3 2014$3,000
+200.0%
26
+160.0%
0.00%
Q2 2014$1,000100.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Key Colony Management, LLC 134,600$13,045,00011.31%
Biondo Investment Advisors, LLC 279,717$27,110,0008.33%
GILDER GAGNON HOWE & CO LLC 3,177,130$307,927,0004.48%
DARUMA CAPITAL MANAGEMENT LLC 814,470$78,938,0003.47%
MAGEE THOMSON INVESTMENT PARTNERS LLC 126,022$12,214,0003.01%
NEXT CENTURY GROWTH INVESTORS LLC 768,396$74,472,0002.63%
MARXE AUSTIN W & GREENHOUSE DAVID M 180,000$17,446,0002.38%
Lisanti Capital Growth, LLC 48,280$4,679,0002.35%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 79,017$7,658,0002.00%
Atika Capital Management LLC 21,500$2,084,0001.60%
View complete list of PACIRA PHARMACEUTICALS INC shareholders